Insight

The evolution of government programs in the U.S.

Balancing opportunity and risk to bring your drug to this important market.

Chris Cobourn, Managing Director, has over 20 years of experience focusing on the evolution of Government Programs. Chris’s main take-away? You only get one chance to do it right, and knowledge of programs requirements is fundamental to maximizing access and building a sustainable compliance program. This message is crucial for companies looking to launch a product in the U.S. drug market, as strict regulations make little room for error.

The evolution of government programs in the U.S.

Balancing opportunity and risk to bring your drug to this important market.

Related content

Our practice

KPMG can help healthcare and life sciences organizations solve their toughest business challenges.

Strengthening the Heart of Healthcare

Connect with KPMG at HIMSS19